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ABSTRACT 
In several countries around the world, Pharmaceutical and Personal Care Products (PPCPs) exist in aquatic environments, a fact that 
increases the awareness within the scientific community with respect to their possible fate and environment effects. This research 
presents a preliminary monitoring of use, consumption and presence of PPCPs in wastewater from a treatment plant in a rural 
area of Pereira (Colombia). Domestic sewage is treated in a septic tank followed by an Up-Flow Anaerobic Filter and its effluent 
is discharged into the Otún River, upstream of the water intake of the supply system of the city. The compounds monitored in this 
research included ibuprofen, naproxen, diclofenac, aspirin, ketoprofen, caffeine, galaxolide, tonalide and dihydrojasmonate. An 
adapted method of multi-residue analysis was used, which is based on solid phase extraction with hydrophilic-lipophilic balance 
cartridges, and determination by gas chromatography-mass spectrometry. The removal efficiencies demonstrated that the treatment 
plant could eliminate less than 50 % of dihydrojasmonate, diclofenac and galaxolide existing in wastewater; concentration of aspirin, 
naproxen and tonalide could only be reduced in 15 %; and caffeine, ibuprofen and ketoprofen were not removed. Results provided 
basic information to decide over the necessity of complementary treatments for effluents from systems with the mentioned units.
Keywords: Medicines, personal care, emerging pollutants, socio-demographic characteristics, domestic wastewater.
RESUMEN 
En muchos países del mundo, los productos farmacéuticos y de cuidado personal (PPCPs) están presentes en el medio acuático, 
aumentando las preocupaciones entre la comunidad científica respecto a sus posibles destinos y efectos ambientales. Esta investigación 
presenta un monitoreo preliminar del uso y consumo de PPCPs y su presencia en las aguas residuales de una planta de tratamiento 
en zona rural de Pereira (Colombia), donde los vertimientos domésticos son tratadas en un sistema tanque séptico-filtro anaerobio 
y cuyo efluente se vierte en el río Otún antes de la bocatoma del acueducto de la ciudad. Los compuestos monitoreados en esta 
investigación incluyen ibuprofeno, naproxeno, diclofenaco, aspirina, ketoprofeno, cafeína, galaxolide, tonalida y dihidrojasmonato. Se 
utilizó un método de análisis multiresiduo adaptado, que se basa en la extracción en fase sólida con cartuchos de balance hydrophilic-
lipophilic y determinación por cromatografía de gases-espectrometría de masas. La planta de tratamiento pudo eliminar menos del 50 % 
del dihidrojasmonato, diclofenaco y galaxolida del agua residual; las concentraciones de aspirina, naproxeno y tonalida sólo fueron 
reducidas en un 15 %, y la cafeína, ibuporfeno y ketoprofeno no fueron removidos. Estos resultados proporcionan información base 
para decidir sobre la necesidad de tratamientos complementarios para los efluentes de estos sistemas de tratamiento.
Palabras clave: Medicamentos, cuidado personal, contaminantes emergentes, características sociodemográficas, agua residual 
doméstica.
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Introduction
The role of medicines in human health is important, but 
they are only one of the determinants of people’s well-
being. Self-medication, non-authorized and inadequate 
prescription, and treatment mistakes are also aspects that 
influence quality of life. In Colombia these problems 
are present and obey to the common practice of sale of 
medication without prescription, lack of training for sale 
personnel, and commercial practices of the industry (World 
Health Organization, 2008). This situation has increased 
the consumption of medicines and the necessity of their 
final disposal when they are no longer needed. 
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There are more than 3000 different substances used as 
medicines, including analgesics, antibiotics, contraceptives, 
beta blockers, lipid regulators, tranquilizers and medicines 
for impotence (Siegrist et al., 2004). At the same time, there 
are thousands of chemical compounds present in products 
for skin, hair and teeth care products, and these are also 
present in soaps and sun blocking lotions (Daughton and 
Ternes, 1999). Some authors have suggested that up to 6 
million of Pharmaceutical and Personal Care Products 
(PPCPs) are commercially available in the whole world, 
and the use of pharmaceutical products is growing from 
3 % to 4 % in weight by year (Daughton, 2004).
Currently, pharmaceutical and personal care products 
have expanded importance on environment issues. They 
are a diverse group of chemical substances used every day 
in human and veterinary medicine, in agriculture and in 
cosmetic care (Ávila and García, 2015); they are included 
in the category of emergent contaminants which have been 
present in our lives for decades, but only a few years ago 
their presence in nature has been particularly confirmed in 
aqueous environments (Moreno et al., 2014). Some of the 
sources of pollution are the wastewaters from hospitals, 
agriculture, industrial and domestic activities, which also are 
present in diffuse discharges as a result of run-offs in areas 
where human and animal wastes are not treated or confined.
Studies undertaken in North America have demonstrated 
that these contaminants are present in 80 % of the rivers 
in the United States (Onesios, 2008) and in drinking water 
in cities, suggesting the existence of certain ecological 
damages that some PPCPs may cause (US-EPA, 2014).
These emergent contaminants may enter to the environment 
through the sewer network, by residues produced during the 
shower (US-EPA, 2014) and also by incomplete metabolic 
excretion from humans or bad disposal of these components 
in water (Kummerer, 2009). Once released in nature, many 
of these compounds persist in wastewater treatment plants 
(WWTP) and are transported to distant places away from 
the generating source (Wu et al., 2009; Walters et al., 
2010). Many of the medicines that enter wastewater may 
be absorbed in the sludge produced in treatment systems, 
which represents a change of the contaminant state from a 
liquid phase to a solid phase, with low or null degradation 
(Gartiser et al., 2007).
The medicines of greater consumption are generally the 
analgesics, due to their purpose of pain relievers. These 
type of pharmaceutical products are classified in narcotics, 
non-narcotic and non-asteroid anti-inflammatory (NSAID). 
The narcotics include codeine, methadone, morphine and 
oxycodone; the non-narcotic analgesics more used are the 
acetaminophen and aspirin; and the renowned NSAIDs 
are diclofenac, fenoprofen, ketoprofen, mefenamic acid, 
indomethacin, naproxen and ibuprofen (Nicholas-Bateman, 
2012). Many of these compounds have been assessed in 
order to find the exposition routes in water and soil, and also 
the environment risk that they represent (Miege et al., 2009).
The synthetic musks are chemical products used for the 
manufacture of fragrances, soap scents, home cleaning 
products, detergents, fabric softeners, shampoo, shaving 
lotions and even herbicides (Nair et al., 1986; Gatermann 
et al., 1995) with a high consumption in the whole world 
(Osemwengie and Gerstenberger, 2004). They have 
been found present in the environment because of their 
high degree of use and liberation, (Rimkus et al., 1994). 
Due to their chemical structure and physicochemical 
properties they have a potential to bio-concentrate and 
bio-accumulate in the soil and the adipose tissue of aquatic 
organisms (Daughton and Ternes, 1999).
The polycyclic musks such as celestolide (ABDI), galaxolide 
(HHCB) and tonalide (AHTN) are commonly more used in 
greater amounts than nitrogenized musks; traseolide (ATII), 
phantolide (AHMI) and cashmeran (DPMI) are employed 
with lesser frequency (Daughton and Ternes, 1999). In 
general, the almost universal consumption of this kind of 
products results in a constant input to wastewater treatment 
plants and to the environment.
Caffeine is consumed in large amounts in beverages and 
in a lesser proportion in the analgesics form; however, its 
presence has been detected in different types of water: 
wastewaters (Sweden, Paxe´us, 1996; Spain, Matamoros, 
2008); surface waters (Czech Republic, Franke et al., 1995; 
in the United States, Gardinali and Zhao, 2002; Ontario 
and Erie lakes in Canada, Metcalf et al., 2003; Spain, 
Huerta-Fontela et al., 2008); seawaters (Canada, Weigel et 
al., 2002; Comeau et al., 2008); and in groundwater (Spain, 
Teijon et al., 2010). In spite of this, the research over the 
distribution of caffeine in the aquatic environment initiated 
a few years ago, and it is found in rivers and aquifers in low 
concentrations in order of ng/L to mg/L.
In this study the habits of consumption and disposal of PPCPs 
were assessed in a semi-urban area (La Florida) located 
upstream from the water supply system of Pereira city 
(Colombia); at the same time, how this compounds may be 
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eliminated or not from the wastewater through a treatment 
system composed by a septic-tank followed by an anaerobic 
filter was also studied. Due to the innovation that this topic 
represents for Colombia, up to date this kind of studies have not 
been reported. It is necessary to characterize the population 
with emphasis on socio-economic variables, affiliation to 
the health system, house sanitation characteristics, and 
information of consumption of pharmaceutical and personal 
care products, in order to assess, in a later phase, their 
presence in domestic wastewaters and their removal in a 
wastewater treatment plant - WWTP.
Experimental Development
Consumption habits determination  
for Pharmaceutical and Personal Care Products
A descriptive transversal study was carried out through a 
population census in La Florida (n = 173 homes) located in 
the middle basin of Otún River, where a member of each 
house was interviewed with questions related to information 
of the family, general characteristics of the property, basic 
sanitation conditions, health and hygiene habits for the family 
members. After the verbally informed consent, participants 
answered a survey adapted from López et al., (2007) through 
a mobile application (Memento Database Pro), in order to 
capture the field data of Census and Georeferenced Surveys 
on line. The aplication was developed by El Centro de 
Sistematización Ambiental S.A.S, Colombia. 
Processing and descriptive analysis of data were carried 
out using the IBM SPSS software (version 20), and the 
construction of graphs was made through Excel 2010.
Water samples
To determine the reduction in concentrations of the studied 
compounds in wastewaters, a monitoring campaign was 
achieved in the wastewater treatment plant (WWTP) of La 
Florida, which is located in the coordinates 4° 45’ 36.64’’ 
N and 75° 36’ 37.52’’ E, upstream of the water intake 
structure of the aqueduct system of Pereira. The average 
intake flow rate of the wastewater system treatment is 2.97 
L/s, and it receives a primary treatment by a Septic-tank and 
a secondary one in an Up-Flow Anaerobic Filter. 
All system treatment has a total hydraulic retention time 
of 15 h, suggesting that the system is overload. To estimate 
the efficiency of the system and its removal of PPCPs, a 
4 L sample was taken at the inflow and outflow during 
four sampling events. Each sampling was made during a 
composition period of 6 h and the assessment of the units 
was carried out during dry season to avoid the affectation 
by rain events. The collected water samples were stored at 
4 °C in amber color glass containers to be processed in the 
Gas Chromatography and Mass Spectrometry laboratory at 
Universidad Industrial de Santander during the following 
seven days. Wastewater was also analyzed for common 
organic parameters such as COD, BOD5 and TSS in order 
to recognize the efficiency of the treatment plant. 
Chemicals and Reagents 
All of the pharmaceutical products (ibuprofen, naproxen, 
diclofenac, aspirin, ketoprofen), stimulants (caffeine), 
and personal care products (galaxolide, tonalide, methyl 
dihydrojasmonate) that were used in the analytic techniques 
of this study were imported reference materials from Sigma-
Aldrich, Steinheim, Germany.
Solid Phase Extraction (SPE)
The SPE was adapted from the method reported by 
Matamoros et al., (2006). All the water samples were filtered 
through a fiberglass paper with a pore size of 0.45  µm and 
a 47 mm diameter in order to be acidified later to a pH 
2 with concentrated chloride acid. A sample volume of 
500 mL was percolated in a polymeric cartridge Strata X, 
previously set with 5 mL of n-hexane, 5 mL of ethyl acetate, 
10 mL of MeOH, and 10 mL of Milli Q water. The filtration 
rate was adjusted to approximately 10 mL min-1. After 
that, the cartridges were dried and, finally, the analytes 
were eluded with 5 mL of ethyl acetate. The extract was 
evaporated until it dried under a soft flow of reconstituted 
nitrogen in 175 µL of methanol.
Gas Chromatography Analysis  
and Mass Spectrometry
As a consequence of the low concentration of PPCPs 
(generally found at trace level in the environment), high 
polarity, thermic instability, and their interaction with 
complex aqueous matrixes, reliable and precise analytic 
processes to measure these compounds are required. 
The use of gas chromatography systems (GC) or a high-
performance liquid chromatography separator (HPLC), 
and the use of qualitative and quantitative analyses with 
different detectors has been the best option. 
Mass spectrometry (MS) presents high selectivity, specificity 
and sensitivity advantages in order to analyze the PPCPs; 
this is the reason why the GC-MS and LC-MS have become 
an indispensable tool in the investigation of these type of 
compounds in environmental matrixes (Hao et al., 2007).
The methodology used for the analyses was GC-MS 
adapted from Matamoros et al. (2005) where the obtained 
extracts in the SPE were analyzed in a Gas Chromatograph 
AT 6890 Series Plus (Agilent Technologies, Palo Alto, 
California, USA.) coupled to a mass selective detector 
operated in ion selective monitoring mode (SIM) (MSD 
5975 Inert XL Agilent Technologies, Palo Alto, California, 
USA). The column used was HP-5 capillary (5 % phenyl, 
95 % dimethyl-polysiloxane) (30 m × 0.25 mm ID, 0.25 µm 
thickness phase); the He gas running was 1.0 mL min-1; the 
injection volume was 2 µL in split less mode. Methylation 
of the carboxylic acid group was carried out on line in a 
hot gas injector supplied with 2 µL of trimethylsulfonium 
hydroxyl solution, TMSH (0.25 mol/L in methanol) at 50 µL 
of sample before the injection.
In the selective ion monitoring mode the following ions were 
selected: methyl ester Ibuprofen, 161/162/177/220; methyl 
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ester naproxen, 170/185/186/244; methyl ester diclofenac, 
214/216/242/309; methyl ester ketoprofen, 191/209/210/268; 
galaxolide, 213/243/244/258; tonalide, 201/243/244/258; 
caffeine, 82/109/165/194; dihydrojasmonate, 83/153/156/226; 
and methyl ester acetylsalicylic acid, 92/120/121/152.
Statistical Analysis 
The results of the removal study were analyzed with the 
statics package IBM SPSS version 20.
Results
Socio-economic characterization  
of the population
Each home has an average of 3.4 inhabitants, and the typical 
range of member ages found were between 19 and 59 years 
old with a 54 % of frequency. The inhabitants above 60 
years were 20 % of the population, and the infants below 2 
years were less than 3 % of the total analyzed population. 
The children between 2 and 12 years old were represented 
by approximately12 %, as well as the adolescents between 
13 and 18 years. 60 % of the residents were associated with 
the contributive official health system (persons with wage pay 
for health services in the official government system) while 
37.5 % belong to the subsidized regime (people covered by 
the official health system). Only 2.5 % of the interviewed 
homes were found lacking any health protection. 
51 % of homes reported an income between COP $190.000 
and COP $600.000, 36 % between COP $616.000 and 
COP $1.232.000, 2 % between COP $1.232.000 and COP 
$1.848.000, and only 3 % had an income above COP 
$1.848.000. 8 % of the homes informed to be living with an 
income below COP $190.000 (the corresponding exchange 
rate from USD to COP for 2014 was $2000.33).33.3 % of the 
people interviewed declared that their income is not enough 
to cover their basic needs, 58.3 % of the total declared that 
their income barely allows them to survive, and only 8.3 % 
affirmed that their wages went beyond the basic needs. 
When inquiring about the socio-economic classification, it 
was found that 19 % of homes were in strata I (low-low), 
76 % were in strata 2 (low) and only 5 % of the homes were 
classified in strata 3 (medium- low). These data represents the 
typical condition of people from rural zones in Colombia.
Regarding access to water and sanitation services, 98 % 
of the interviewed homes had water from the local 
aqueduct system, and only 2 % were supplied by a water 
spring. 83 % of properties discharge their wastewater in 
the sewer system and 12 % treats it through an individual 
decentralized treatment plant (55 % of these homes know 
how to perform maintenance to their systems, while the 
remaining 45 % does not know how to do it); only 5 % of 
homes directly discharge the effluents to a surface source 
and to the ground. Just 91 % of the homes confirmed that 
they deliver the solid wastes to a collection vehicle.
La Florida is a semi-urban community with a great 
deal of population belonging to low socio-economical 
classification, good basic sanitation indexes, a high rate of 
affiliation to health system, and a low level of education. 
Pharmaceutical and personal care products 
consumption habits 
Concerning health habits, 79 % of the inhabitants of the 
surveyed homes consume medicines, while 21 % indicated 
that they do not. The consumption habits are divided in 
equal parts (50 %) among those who have a daily use and 
those who only use them when symptoms arise. Among the 
criteria used to buy a medicine, the medical prescription 
is prevalent (69 %), followed by self-medication (27 %), 
and mixed prescription/self-medication (4 %). Regarding 
consumption orientation, 79 % of the interviewed people 
declared that the doctor gives them a prescription, 13 % 
were oriented by family suggestions, and 8 % by the 
pharmacist, friends or publicity. 
The interrogated people reported a total use of 37 
medicines: 1. Acetaminophen (paracetamol), 2. Aspirin 
(acetylsalicylic acid), 3. Alapril (halazepam), 4. Alercet 
(cetirizine), 5. Amiodarone, 6. Amlodipine, 7. Amoxicillin, 
8. Astonin (fludrocortisone), 9. Atorvastatin, 10. Bromide of 
Ipratropium, 11. Buscapine (paracetamol and scopolamine), 
12. Calcium, 13. Cephalexin, 14. Descongel (paracetamol, 
loratadine, phenylephrine), 15. Diclofenac, 16. Dinitrate 
Isosorbide, 17. Dolex (acetaminophen, phenylephrine), 18. 
Furosemide, 19. Glibenclamide, 20. Hydrochlorothiazide, 
21. Hydrocortisone, 22. Ibuprofen, 23. Insulin, 24. 
Ketoprofen, 25. Metformin, 26. Metoprolol, 27. Naproxen, 
28. Metformin, 29. Nifedipine, 30. Noraver (ibuprofen, 
phenylephrine, levocetirizine), 31. Noxpirin (paracetamol, 
caffeine, cetirizine), 32. Piroxicam, 33. Prednisolone, 
34. Robitusin (dextromethorphan, hydrobromide), 35. 
Salbutamol, 36. Saline solution, and 37. Tyrosine.
Medicines of greater consumption in the population are 
non-asteroid anti-inflammatory (NSAIDs). Among these, 
the most popular is acetaminophen (medicine with 
analgesic properties) with a 27 %: medicines sold without 
medical prescription such as aspirin (6.5 %), ibuprofen 
(4.5 %), naproxen (2.4 %) and diclofenac (2.4 %) were also 
featured.
Other medicine groups that are highlighted are 
those prescribed for high blood pressure treatment 
(amlodipine-5 %; enalapril-7 %; losartan-11 %); for 
treatment of hyperthyroidism (levothyroxine-3 %); for 
lowering cholesterol level (lovastatin-10 %); and for use 
as diuretics (furosemide-3 %; hydrochlorothiazide-7 %). 
Medicines used for diabetes control are also reported 
(insulin-2 %; metformin-5 %), and for the treatment of 
common cold (noxpirin-3 %).
The reported dosages differ from each medicine consumed, 
and depend on the purpose of each one. As an example, 
acetaminophen is administered orally in every case with 
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dosages varying between 250 to 500 mg from one to three 
times per day. The same occurs with medicines used to treat 
common colds such as noxpirin (paracetamol, caffeine, 
and cetirizine), dolex (acetaminophen, phenylephrine) and 
descongel (Phenylephrine hydrochloride, loratadine, and 
acetaminophen) that have treatments up to three days with 
a dosage of pills every 8 to 12 hours. On the other hand, 
the medicines used for the treatment of blood pressure vary 
between 20 and 150 mg in doses per day during a lifetime 
treatment as well as the treatment for kidney illness and 
diabetes. The antibiotic treatments with amoxicillin were 
reported under a dosage of 500 mg for three times a day 
during one week period. In general, the most common 
doses were administered orally, and the least common 
administration is the injection, reported for medicines such 
as insulin and diclofenac. The NSAIDs were testified as 
occasional use and their treatment depends on the response 
from the patient.
Once the medical treatments are finished, it is very common 
for people to dispose the leftover medicines. Most of them 
(59 %) dump the products with the domestic solid wastes 
while 9.3 % disposes them through the sanitary unit. 17 % 
of the people gives the medicines as a gift to other people, 
and the remaining 15 % reported taking them to a pharmacy 
for their appropriated and controlled disposal. It is assumed 
that at least 37 active different pharmaceutical principles 
(apart of their degradation metabolites) are incorporated 
into the domestic wastewater due to the use of medicines. 
Currently, the mentioned compounds are not monitored in 
Colombia, neither are there laws in the country to monitor 
and control this. 
According to data, there was no difference between the 
income and the type of medicines consumed, neither any 
correlation between consumption characteristics by family 
group and the reported income in this study case.
On the level of personal care products, the people 
interviewed were asked about the frequency of use, amount 
and purchase frequency. From the answers, it was possible 
to recognize that the daily use of ten personal care products 
and their emergent contaminant molecules are probably 
discharged in domestic wastewaters (Table 1).
A wide range of chemical compounds such as personal 
care products, surfactants, plasticizers and industrial 
additives are not included in the current monitoring of 
water treatment programs, but they are incorporated as 
new chemical compound synthesis that needs changes in 
the use and disposal, because up to date there is a limited 
available information on the effect that they may cause on 
human health and on the environment (Smital, 2008).
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PPCPs Presence in wastewater
Based upon the collected information from the surveys and 
on different studies that report the presence of PPCPs in 
wastewater, it was decided to evaluate the products related 
in Table 2, and their possible removal from wastewater 
in the treatment system of the rural area of La Florida 
(Pereira). The assessed medicines are free-sale products and 
commonly used by the assessed population. On the other 
hand, the selection of compounds derived from personal 
care products is due to their presence in daily use elements 
reported by people (Table 1).
Table 2. Influent and effluent concentrations of assessed PPCPs
Parameter
Influent Effluent
Max. Min.n. Ave. Max. Min. Ave.
Aspirin (µg/L) 5.5 3.9 4.3 4.8 3.9 4.1
Caffeine (µg/L) 11.1 0.1 5.5 15.2 1.0 8.1
Cis-MDJM (µg/L) 31.8 4.7 15.7 11.5 7.4 9.1
Diclofenac (µg/L) 78.7 1.1 21.6 13.6 1.1 5.3
Galaxolide (µg/L) 39.2 5.7 16.0 17.6 0.1 7.2
Ibuprofen (µg/L) 0.7 0.1 0.3 2.1 0.1 0.9
Ketoprofen (µg/L) 1.7 0.8 1.3 2.4 0.8 1.5
Naproxen (µg/L) 2.0 0.4 1.1 4.8 0.9 2.3
Tonalide (µg/L) 6.3 2.2 3.4 6.6 2.2 3.4
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Measured PPCPs presented trace level concentrations 
(µg/L) in the influent and effluent of the treatment systems 
(Table 2), and this has been commonly reported for this 
type of organic micro-contaminants existing in wastewater 
(Verlichi et al., 2012). The described concentrations are in 
a wide range of values due to use/consumption variations 
of those products and their metabolism degree in humans 
(Miège et al., 2009). 
The compounds that present higher average concentrations 
in the treatment system are diclofenac (21.6 µg/L), methyl-
dihydrojasmonate (15.7 µg/L) and galaxolide (16 µg/L). 
The remaining group of assessed compounds presents 
concentrations below 6 µg/L. For all PPCPs evaluated, the 
removal efficiencies may be estimated as low. Comparing 
influent and effluent concentrations (Figure 1), the removal 
rates were below 50 % for compounds such as methyl-
dihydrojasmonate, diclofenac and galaxolide; below 15 % 
for aspirin, naproxen and tonalide, and no removal rates 
for caffeine, ibuprofen and ketoprofen. This fact agrees 
with the information reported by other authors in which 
conventional treatment systems do not have a wide removal 
capacity for this type of emerging contaminants (Suarez et 
al., 2008; Dordio et al., 2010).
It is difficult to say that the reported efficiencies are 
typical for the system assessed, since results in different 
investigations show a high variation in the removal 
percentages in conventional treatment systems. Such 
uncertainty is attributed to the variability in the rate of 
PPCPs consumption, the metabolism of the consumers, 
the wastewater generation rates, the persistence in the 
environment of such substances, and the efficiency in the 
treatment processes (Petrovic et al., 2009; Jelic et al., 2012). 
Figure 1. Removal efficiency of PPCPs (error level = 5 %)
The removals of galaxolide and tonalide are close to 
the average values mentioned by Luo et al. (2014), who 
report removals of galaxolide and tonalide between 
15 and 30 % with biological degradation as one of the 
responsible mechanisms. Low removal rates of ibuprofen 
and naproxen may be presumably attributed to their low 
adsorption of sludge particles in primary treatment units. 
Regarding ketoprofen and diclofenac, low removals 
may be indorsed to compound structure characteristics 
(aromatic rings in ketoprofen and chloride molecule in the 
structure of diclofenac) that turns them into recalcitrant 
compounds (Matamoros et al., 2009), and therefore 
difficults their removal. Caffeine is commonly informed as 
the most abundant PPCP in wastewater, reaching removal 
efficiencies above 80 %; however, for the assessed case, no 
reduction concentration was reported.
Several authors agree that the principal removal mechanisms 
of PPCPs in water treatment systems are biodegradation, 
sorption in filtering media/particulate material, filtration, 
chemical oxidation and volatilization (Miège et al., 2009; 
Guerra et al., 2014); those mechanisms may be either 
favored or not by the operational conditions of each system 
and the characteristics of the wastewater to be treated. This 
is the reason why it is difficult to confirm the persistence 
of each component in the studied treatment system and it 
is suggested to undertake more investigations that allow 
to identify the possible routes and removal mechanisms 
involved in this kind of treatment system.
The reported removals in this investigation are not 
surprising when considering that the assessed biological 
treatment system (ST-UFAF) is designed for the removal of 
conventional parameters such as BOD5, COD and TSS, 
that present concentrations in the level of de mg/L (Ratola 
et al., 2012; Patiño et al., 2014), but not for the removal of 
organic micro-contaminants and their metabolites (Igos et 
al., 2012). The wastewater treatment plants are considered in 
fact as a retention point and later liberation of PPCPs to the 
environment (Jelic et al., 2012b; Wang et al., 2015), because 
the physical and chemical properties of the PPCPs (solubility, 
volatility, absorbability, absorbability, biodegradability, 
polarity and stability) vary considerably in wastewater and 
depend on the operational conditions of the treatment 
systems (Verlichi et al., 2012; Yunlong et al., 2014). 
On the topic of organic matter parameters used to assess the 
wastewater treatment systems operation, the arrangement 
of septic tank and anaerobic filter units in this research 
displayed an efficiency removal higher than 50 % for 
CDO, BOD and TSS, as presented in Table 3. These data 
represent a low efficiency in this kind of systems treatment 
since the typical percentage for organic matter removal in 
this combination units is reported between 80 and 90 % 
(Sperling, 2012). 
Table 3. Organic loads and efficiency removal
Parameter
Organic loads % efficiency 
ST-AFInfluent Septic Tank Effluent Anaerobic Filter
BOD (kg/d) 56,7 28,3 50,09
COD (kg/d) 27,4 11,9 56,80
TSS (kg/d) 25,2 10,4 58,71
According to the results found in this study, the presence 
of PPCPs after the discharge on Otún River of the treated 
wastewater in La Florida is expected; however, we must 
emphasize that these pollutants, despite the current 
importance worldwide, are not yet considered as priority 
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compounds for evaluation within the existing regulatory 
framework in Colombia. In this sense, we should not rule out 
the need to continue researching on these traces of emerging 
contaminants and the potential technological alternatives 
that can be implemented for their removal in wastewater. 
Conclusions
In the rural area of La Florida it is recognized that the use of 
medicines and personal care products are due to consume 
practices not only by medical prescription but also by 
self-medication, which encourage the indiscriminate 
use of these products. As a consequence, and due to the 
lack of monitoring of PPCPs in the discharges of domestic 
wastewater, the uncertainty about the effect of the active 
components that are not absorbed by the human body and 
later discharged to the water sources increases.
The medicines consumed by the people from the 
evaluated area in this research are principally used as 
anti-inflammatories, analgesics, blood pressure control, 
diuretics, and for diabetes and high cholesterol treatments. 
Therefore, it was found that around 37 active pharmaceutical 
principles and their degradation metabolites can be 
incorporated into the domestic sewages that feed the 
anaerobic system treatment used in the study area.
All the analyzed personal care products and their active 
principles are defined as emerging contaminants. The purchase 
volume and frequency of use makes their concentrations 
in the effluents constant in time, causing an environment 
contamination risk that must be studied in detail. Even the 
persistence and risk for the water supply system downstream 
of the WWTP in the city must be evaluated.
The PPCPs of the produced wastewater in the study area 
were founded in typical concentration ranges; however, 
their reduction through the ST-AF system did not show to 
be very significant for most of the emergent contaminants 
assessed, mainly for caffeine, ibuprofen and ketoprofen, 
which are medicines with common use due to their wide 
usefulness and ease of access. The compounds with more 
reduction concentration in the treatment system were 
methyl-dihydrojasmonate, diclofenac and galaxolide, 
but nevertheless they did not reach removal efficiencies 
higher than 50 %. This result might be complemented 
by the operation conditions of the treatment plant, which 
showed organic matter removal between 50 and 60 %. This 
state should be checked due to the necessity to extend the 
hydraulic retention time from each treatment unit, as well 
as to allow better environments for the biological processes 
that occur inside reactors and perhaps contribute to PPCPs 
removal mechanisms. 
Nowadays in Colombia, the monitoring of these kind of 
compounds is scarce and no regulations on these discharges 
are present in the laws; hence, it is suggested that national 
researchers invest in efforts to assess new depuration systems 
that allow the removal of this substances that are arriving to 
the domestic and industrial effluents, and that may indirectly 
be passed to the supply systems of drinking water.
It is recommended to start investigations on alternative 
treatment systems in order to reduce the concentrations of 
these contaminants in water. At the same time, a continuous 
monitoring campaign must be undertaken to allow an 
adequate control over the contaminant discharges of PPCPs 
in the water supply systems of the City of Pereira.
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